February 14, 2022
Elite Diagnostic Limited booked a 22% increase in revenue to total $288.37 million from $236.07 million booked the same period in 2020. Revenue for the second quarter rose by 17% to $147.54 million (2020: $126.36 million).
Direct costs for the period increased 13%, closing at $97.19 million, up from $86.31 million reported the prior year, while for the second quarter there was a 7% increase year over year to $47.13 million (2020: $43.97 million).
As such, gross profit for the six months amounted to $191.18 million, reflecting a growth of 28% when compared to $149.76 million recorded last year. Gross profit, for the second quarter ended December 31, 2021, increased 22% to $100.42 million from $82.39 million for the corresponding period in 2020.
Administrative expenses climbed by 24% for the period, to total $114.88 million (2020: $92.46 million). Depreciation and amortization also increased by 8% to total $54.73 million relative to the $50.55 million booked in 2020. This resulted in profit from operations of $21.58 million, a significant increase relative to $6.75 million booked in the same period a year ago.
Finance Cost for the six months totalled $11.33 million, 10% up when compared to the $10.32 million recorded for the same period last year, while foreign loss amounted to $3.67 million relative to foreign loss of $3.70 million the prior year’s comparable period. Other income closed the period at $163,555 (2020: $20,161)
Profit before tax totalled $6.75 million compared to a loss of $7.25 million recorded last year. Following no income tax for the period, net profit for the period totalled $6.75 million relative to a loss of $7.25 million recorded the prior corresponding period. Whereas, net profit for the quarter amounted to $7.26 million, a 135% increase compared to $3.09 million booked for the prior quarter of 2020.
Earnings per share (EPS) for the period totalled $0.02 (2020: LPS $0.02). EPS for the fourth quarter amounted to $0.02 (2020: $0.01). The trailing twelve-month EPS amounted to $0.017. The number of shares used in our calculations amounted to 353,400,000 units. ELITE’s stock price closed the trading period on February 11, 2022, at $3.49 with a corresponding P/E of 202.10 times.
Balance Sheet at a glance:
As at December 31, 2021, total assets amounted to $778.03 million, up 13% from the $687.12 million reported as at the previous year. The increase in total assets was as a result of ‘Deposit on Equipment’ amounting to $94.55 million (2020: nil).
Shareholders’ Equity of $442.01 million was reported (2020: $452.51 million) which resulted in a book value per share of $1.25 (2020: $1.28).
Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
